EC Number   |
Application |
Reference |
|---|
    3.1.1.5 | medicine |
cryptococcal phospholipase B1 is a virulence factor |
681298 |
| 3.1.1.5 | medicine |
LLPL activity is anti-atherogenic and the regulation of this enzyme might be a novel drug target for the treatment of atherosclerosis |
663870 |
| 3.1.1.5 | medicine |
Schistosome lysophospholipase may represent a new target for anti-schistosomal chemotherapy |
680233 |
| 3.1.1.5 | medicine |
schistosome lysophospholipase may represent a new target for anti-schistosomal-chemotherapy |
680233 |
| 3.1.1.5 | medicine |
the cytotoxic potential and signalling properties enable Legionella pneumophila PLA, LPLA enzymes to act as bacterial virulence factors, involved in severe lung disease |
692675 |
| 3.1.1.5 | medicine |
the phospholipases and lysophospholipases expressed by eosinophils or other airway cells may represent therapeutic targets for blocking surfactant degradation, dysfunction and peripheral airway closure in asthma |
680335 |
